MedTrace Logo

HUMSCs Combined With Col I to Third-Degree Burn Wound

NCT07530003 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-05-04

No results posted yet for this study

Summary

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.

Conditions

  • Burn Wounds
  • Third-Degree Burn Wounds

Interventions

COMBINATION_PRODUCT

HUMSCs combined with bovine type I collagen

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds

BIOLOGICAL

bovine type I collagen

To evaluate the safety and tolerability of bovine type I collagen in the treatment of third-degree burn wounds

DEVICE

Sterile blank dressing / Vaseline gauze

To evaluate the safety and tolerability of sterile blank dressing / vaseline gauze in the treatment of third-degree burn wounds.

Sponsors & Collaborators

  • The First Affiliated Hospital of Xinxiang Medical College

    lead OTHER

Principal Investigators

  • Wenjie Ren · The First Affiliated Hospital of Xinxiang Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-06
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07530003 on ClinicalTrials.gov